amoxicillin has been researched along with Morbid Obesity in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cerqueira, RM; Correia, M; Manso, MC; Vilar, H | 1 |
Carli, T; Kaliterna, N; Pintar, T | 1 |
Antunes, NJ; de Albuquerque Lima Babadopulos, RF; de Moraes, MEA; de Moraes, MO; De Nucci, G; do Nascimento, DF; Fechine, FV; Lemos, FN; Mendes, GD; Rocha, MBS; Rohleder, AVP | 1 |
Cerqueira, RM; Correia, MR; Manso, MC; Vilar, H | 1 |
Crowell, R; Ereifej, LK; Schade, D | 1 |
Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC; Martins, P; Nora, M; Vilar, H | 1 |
Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC; Vilar, H | 1 |
Abdullahi, M; Annibale, B; Capoccia, D; Lahner, E; Leonetti, F; Osborn, J; Severi, C; Tari, R | 1 |
1 trial(s) available for amoxicillin and Morbid Obesity
Article | Year |
---|---|
Impact of Bariatric Surgery on the Pharmacokinetics Parameters of Amoxicillin.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Chromatography, Liquid; Female; Gastric Bypass; Humans; Male; Middle Aged; Obesity, Morbid; Tandem Mass Spectrometry; Weight Loss | 2019 |
7 other study(ies) available for amoxicillin and Morbid Obesity
Article | Year |
---|---|
Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Consensus; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Proton Pump Inhibitors; Young Adult | 2018 |
The need for a patient-tailored Helicobacter pylori eradication protocol prior to bariatric surgery.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bariatric Surgery; Body Mass Index; Clinical Protocols; Drug Therapy, Combination; Esomeprazole; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Obesity, Morbid; Precision Medicine; Preoperative Care; Retrospective Studies; Young Adult | 2018 |
How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery?
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Obesity, Morbid; Portugal; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2016 |
Rare complication of a common obesity procedure.
Topics: Amoxicillin; Bariatric Surgery; Clavulanic Acid; Female; Gastroplasty; Humans; Middle Aged; Obesity, Morbid; Pneumonia, Aspiration | 2016 |
Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery--fourteen days superior to seven days?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Obesity, Morbid; Proton Pump Inhibitors; Retrospective Studies | 2011 |
Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Ofloxacin; Portugal; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Surgical Wound Infection; Treatment Failure; Young Adult | 2013 |
The eradication of Helicobacter pylori is affected by body mass index (BMI).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Body Mass Index; Clarithromycin; Comorbidity; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Multivariate Analysis; Obesity, Morbid; Pantoprazole; Pilot Projects | 2008 |